ADAMA Ltd.

  Independent Opinions on the Relevant Issues of the
      16th Meeting of the 9th Session of the Board of
                                  Directors

In accordance with the Company Law of the People’s Republic of China, Rules for
Independent Directors of Listed Companies, and other laws, regulations and
normative documents, as well as the Articles of Association and Independent Director
System, we, as the independent directors of ADAMA Ltd. (hereinafter referred to as
“Company”), give our independent opinions on the relevant proposal of the 16th
Meeting of the 9th Session of the Board of Directors from the standpoint of
independent judgment:

1. Independent Opinion on Credit Facilities of USD 50 million from the Related
   Party

The Company's wholly-owned subsidiary, Adama Agricultural Solutions Ltd.
("Solutions"), (through its subsidiary, Adama Fahrenheit B.V.) is contemplating
amending the previously approved agreement with the Company's controlling
shareholder - Syngenta Group Co., Ltd.’s subsidiary, Syngenta Group (NL) B.V., for
the provision of an additional amount of USD 50 million (to an aggregate amount of
USD 100 million committed short-term credit facility) under same terms as the
current committed short-term credit facility approved in October 2021, in order to
expand the funding sources of Solutions and is normal business operations. The
Transaction conforms to relevant national laws and regulations, as applicable, and
market-oriented principles, and will not influence the independence of the Company
or damage the interests of the Company and its other shareholders. The
decision-making procedures for the Transaction conform to the Company Law, the
Rules of Shenzhen Stock Exchange for the Listing of Stocks, the Articles of


                                         1
Association of the Company and other laws and regulations. Therefore, the
independent directors approved the Transaction.




                                         2
 (The signature page of Independent Opinions on the Relevant Issues of the 16th
Meeting of the 9th Session of the Board of Directors)



Independent Director Signature:




__________________                                  ___________________

      Ge Ming                                            Xi Zhen




                                                              December 14, 2022




                                          3